Agata Różycka | Neurogenetics | Best Researcher Award

Published on by Neuroscientists

Dr. Agata Różycka | Neurogenetics | Best Researcher Award

Dr. Agata Różycka, Poznan University of Medical Sciences, Poland.

Dr. Agata Różycka is a molecular neuroscientist and university lecturer at Poznan University of Medical Sciences, specializing in the molecular biology of neurodegeneration, epilepsy, and aging. With a robust academic background that combines molecular biology and pharmacy, she brings together clinical relevance and genetic insight. Her research delves into oxidative stress, genetic polymorphisms, and signal transduction in neurological diseases, with significant contributions to personalized medicine. She is also an accomplished educator, known for delivering high-quality instruction across medical and life science programs. Her scholarly work, published in respected journals and cited widely (h-index 15), continues to impact the fields of neurobiology and molecular diagnostics.

Profile

Orcid

 

🎓 Early Academic Pursuits

Dr. Agata Różycka’s journey in science began with a strong foundation in Molecular Biology and Pharmacy, having completed her MSc and PhD at Adam Mickiewicz University and the Poznan University of Medical Sciences in Poland. From early on, her academic interests were drawn to the molecular intricacies of the brain and human physiology. Her dual institutional training provided her with a broad yet profound grasp of pharmacogenomics, neurobiology, and genetic mechanisms underpinning disease processes. Her graduate years were marked by a passion for decoding the language of DNA and understanding the cellular responses to oxidative stress and genetic variation.

🧠 Professional Endeavors in Neuroscience

Currently a University Lecturer in the Department of Biochemistry and Molecular Biology at the Poznan University of Medical Sciences, Dr. Różycka has dedicated her career to unraveling the molecular foundations of neurological disorders, particularly neurodegeneration, epilepsy, and aging-related changes. Her teaching spans key courses in biochemistry, diagnostics, molecular biology, and laboratory techniques, and she has taught across diverse departments including medicine, nutrition, and biotechnology. Her lectures are known for clarity and depth, consistently earning high evaluations from students, a reflection of her commitment to excellence in scientific education.

🧬 Contributions and Research Focus

Dr. Różycka’s research is defined by its focus on the molecular and genetic mechanisms of neurodegeneration and neurological diseases. She has explored the role of oxidative stress, genetic polymorphisms, and signal transduction pathways in brain aging and epileptogenesis. Her expertise in SNP genotyping, DNA/RNA analysis, and genotoxicity assays has positioned her as a respected figure in the field. Her groundbreaking work on the expression of neuronal nicotinic acetylcholine receptors and the effects of memantine on oxidative DNA damage in aging brains, published in the International Journal of Molecular Sciences in 2025, exemplifies her translational approach to neurodegenerative research.

🧪 Innovation in Molecular Medicine

Beyond basic neuroscience, Dr. Różycka has contributed significantly to the personalized medicine landscape. Her investigations into COMT, MAO-A, and NET gene polymorphisms have improved our understanding of neuropsychiatric conditions like Parkinson’s disease and menopausal depression. Her 2021 study on serotonin polymorphisms and their relation to postoperative pain and nausea in the Journal of Personalized Medicine reflects her interdisciplinary reach, connecting genetics, neurobiology, and clinical practice to enhance patient outcomes.

📚 Academic Influence and Impact

With 682 citations and an h-index of 15, Dr. Różycka’s body of work has earned global recognition in the neuroscientific and biomedical communities. Her contributions are actively followed on platforms such as ORCID, ResearchGate, and Academia.edu, where her network of collaborators and readers continues to grow. Through these forums, she has shaped critical discourse in molecular neuroscience and neuropharmacology, helping researchers worldwide explore new diagnostic and therapeutic frontiers.

🏆 Recognition and Mentorship

Dr. Różycka’s academic excellence extends to mentorship and community engagement. As an educator, she has inspired many budding scientists, fostering critical thinking and hands-on skills in molecular lab techniques. Her reputation for nurturing scientific curiosity and rigor among students is matched by her ability to integrate cutting-edge research into the classroom. Her enduring impact is also evident in the numerous collaborations and citations her work has garnered, reflecting both peer appreciation and scholarly relevance.

🔬 Legacy and Future Contributions

Looking forward, Dr. Różycka aims to delve deeper into epigenetic mechanisms and neuroprotective strategies in aging brains. Her future projects include investigating novel therapeutic targets within cholinergic and serotonergic pathways, with the long-term vision of contributing to early intervention in age-related cognitive decline and epilepsy. As neuroscience continues to evolve, her legacy will be marked by a rare blend of precision science, passionate teaching, and a visionary approach to human health.

Publication

  • Title: Expression of Neuronal Nicotinic Acetylcholine Receptor and Early Oxidative DNA Damage in Aging Rat Brain—The Effects of Memantine
    Authors: Małgorzata Anna Lewandowska, Agata Różycka, Teresa Grzelak, Bartosz Kempisty, Paweł Piotr Jagodziński, Margarita Lianeri, Jolanta Dorszewska
    Year: 2025

 

  • Title: Relationship of Postoperative Pain and PONV after Minimally Invasive Surgery with the Serotonin Concentrations and Receptors’ Gene Polymorphisms
    Authors: Natalia Ignaszak-Kaus, Antoni J. Duleba, Aleksandra Mrozikiewicz, Grażyna Kurzawińska, Agata Różycka, Jan Hauke, Michał Gaca, Leszek Pawelczyk, Paweł Piotr Jagodziński, Piotr Jędrzejczak
    Year: 2021

 

  • Title: Importance of polymorphic variants of phosphatidylethanolamine N-methyltransferase (PEMT) gene in the etiology of intrauterine fetal death in the Polish population
    Authors: Agnieszka Seremak-Mrozikiewicz, Magdalena Barlik, Agata Różycka, Grażyna Kurzawińska, Andrzej Klejewski, Hubert Wolski, Krzysztof Drews
    Year: 2018

 

  • Title: The MAOA, COMT, MTHFR and ESR1 gene polymorphisms are associated with the risk of depression in menopausal women
    Authors: Not fully listed, but includes Agata Różycka (complete list available in source)
    Year: 2016

🔚 Conclusion

Dr. Agata Różycka stands out as a leading figure in the intersection of molecular neuroscience and clinical genetics, with a proven track record of impactful research and dedicated teaching. Her innovative studies on aging brains, gene polymorphisms, and neurotransmitter systems not only advance scientific understanding but also bridge the gap between molecular theory and patient care. With ongoing projects focused on epigenetic regulation and neuroprotective strategies, her work promises to shape the future of neurological health and personalized therapeutics.

 

 

Sarah Coulette | Neurogenetics | Best Researcher Award

Published on by Neuroscientists

Dr. Sarah Coulette | Neurogenetics | Best Researcher Award 

Dr. Sarah Coulette, Hospital Fondation Adolphe de Rothschild, France.

Dr. Sarah Coulette is a highly accomplished French neurologist based at the Rothschild Foundation Hospital in Paris. With a strong academic foundation from Toulouse and Montpellier, she has accumulated over eight years of clinical experience in neurology. Her expertise spans multiple sclerosis, Parkinson’s disease, EMG, and oculomotor disorders, with specialized skills in video-oculography. Dr. Coulette’s research has produced impactful publications and conference presentations, notably in areas such as SCA27B, Susac Syndrome, and cerebral amyloid angiopathy. She is recognized for her translational approach, using imaging and electrophysiological tools to enhance diagnostic precision. Her work stands at the intersection of advanced clinical care, academic leadership, and innovative diagnostics, making her a respected figure in both clinical and research spheres.

Profile

Orcid

 

🎓 Early Academic Pursuits

Dr. Sarah Coulette began her distinguished medical journey in Toulouse, where she obtained her medical degree, establishing a robust foundation in clinical medicine. Her passion for neurology led her to pursue a specialized residency (DES) and internship in Montpellier, an environment known for its excellence in neurological education. During her formative years, Dr. Coulette developed an early interest in neurodegenerative and demyelinating disorders, particularly exploring how clinical presentation aligns with neuroimaging and electrophysiological findings. Her dedication culminated in the successful defense of her medical thesis in 2017, focusing on cerebral amyloid angiopathy-related inflammation—an ambitious and insightful project that was later published and presented at multiple prestigious forums.

🏥 Professional Endeavors

Following her residency, Dr. Coulette further advanced her clinical expertise by joining the Rothschild Foundation Hospital in Paris—an esteemed institution recognized for neurological innovation. There, she completed a competitive fellowship as a Chief Clinical Assistant (CCA), immersing herself in complex neurological diagnostics and patient management. As a practicing neurologist in the Department of Neurology, she now contributes daily to the diagnosis and treatment of conditions such as multiple sclerosis, Parkinson’s disease, and rare neuro-ocular syndromes. Her clinical acumen is further strengthened by her proficiency in electromyography (EMG) and video-oculography, placing her at the forefront of diagnostic neurology.

🧠 Contributions and Research Focus

Dr. Coulette’s research is deeply rooted in translational neuroscience, bridging clinical observation with advanced imaging and electrophysiology. She has made significant contributions to the understanding and diagnosis of disorders such as spinocerebellar ataxia type 27B (SCA27B), Susac Syndrome, and cerebral amyloid angiopathy. Her work on Video-Oculography as a diagnostic tool for SCA27B and her exploration of 4-Aminopyridine’s effects on downbeat nystagmus highlight her focus on functional, patient-centric innovation. Moreover, her investigations into magnetic resonance post-contrast FLAIR imaging in Susac Syndrome reflect her commitment to refining diagnostic accuracy in neuroinflammatory diseases.

🏆 Accolades and Recognition

Dr. Coulette’s academic excellence and research acumen have earned her recognition on both national and international stages. Her poster on SCA27B was presented at the Movement Disorder Society in Philadelphia (2024), and her oral presentation on Susac Syndrome was well received at the European Stroke Organization conference in Göteborg (2018) and SFNV the same year. These accomplishments underscore her credibility as a rising thought leader in neurology, consistently contributing meaningful insights to professional communities and peer-reviewed publications.

🔬 Impact and Influence

With over eight years of clinical experience, Dr. Coulette has become a trusted figure in the French neurology landscape. Her clinical interventions, guided by cutting-edge research and precision diagnostics, have directly improved patient care. Through her publications, she has contributed to broader scientific understanding, enabling other clinicians and researchers to refine their diagnostic frameworks and therapeutic strategies. Her collaborative approach and multidisciplinary knowledge make her an influential contributor to the advancement of neurodiagnostic science.

🧬 Legacy and Future Contributions

Dr. Coulette continues to merge clinical expertise with investigative curiosity, envisioning a future where electrophysiological techniques and neuroimaging tools are seamlessly integrated into personalized treatment pathways. Her ongoing work on demyelinating diseases, particularly multiple sclerosis, promises to shape future therapeutic guidelines. She remains dedicated to fostering clinical research that directly enhances patient outcomes, especially in disorders marked by diagnostic ambiguity. Dr. Coulette’s trajectory suggests a future filled with academic innovation and compassionate care, setting a lasting example for future neurologists.

📚 Knowledge Beyond the Clinic

In addition to her clinical and research commitments, Dr. Coulette engages in academic mentoring and educational initiatives aimed at nurturing the next generation of neurology professionals. She advocates for the practical application of diagnostic technologies in medical training and actively participates in conferences, sharing her insights with both seasoned experts and young trainees. Her role as a clinician-researcher places her at the nexus of academic rigor and medical empathy, embodying a model of neurologic excellence that inspires continuous learning and collaboration.

Publication

  • Title: Diagnosis and Prediction of Relapses in Susac Syndrome: A New Use for MR Postcontrast FLAIR Leptomeningeal Enhancement

  • Authors: S. Coulette, A. Lecler, E. Saragoussi, K. Zuber, J. Savatovsky, R. Deschamps, O. Gout, C. Sabben, J. Aboab, A. Affortit, et al.

  • Year: 2019

 

✅ Conclusion

Dr. Sarah Coulette exemplifies the modern clinician-scientist—deeply engaged in patient care while actively pushing the boundaries of neurological science. Her blend of clinical excellence, research innovation, and academic mentorship positions her as a future leader in neurology. With a clear commitment to improving diagnostic methodologies and patient outcomes, her influence is set to grow both within France and internationally. Dr. Coulette’s journey highlights the vital role of neurologists who not only treat but also discover, teach, and inspire.

Mehveş PODA | Neurogenetics | Best Researcher Award

Published on by Neuroscientists

Assist. Prof. Dr. Mehveş PODA | Neurogenetics | Best Researcher Award

Assist. Prof. Dr. Mehveş PODA, Istanbul University, Aziz Sancar Inst. of Experimental Medicine, Genetic Department, Turkey.

The individual is a highly accomplished geneticist with a strong academic foundation, beginning with a BSc in Molecular Biology and Genetics from Boğaziçi University, followed by an MSc and PhD in Medical Genetics from Istanbul University. Her professional career has been anchored at the prestigious Aziz Sancar Institute of Experimental Medicine, where she currently serves as an Assistant Professor. Her research spans rare genetic diseases, gene expression in pancreatic cancer, neuromuscular disorders, and third-generation sequencing technologies. With over 70 publications and an H-index of up to 8, she has significantly contributed to molecular genetics and clinical applications, earning citations and respect within the scientific community. Her multilingual abilities, project management certification, and involvement in genetic epidemiology further enhance her impact in both research and education.

Profile

Google Scholar

🎓 Early Academic Pursuits

From the outset, a passion for genetics and molecular biology defined her academic journey. She earned her BSc in Molecular Biology and Genetics from Boğaziçi University in 1993, a highly respected institution that laid a strong foundation in life sciences. Her keen interest in hereditary conditions led her to pursue an MSc in Medical Genetics at Istanbul University, where her 1996 thesis focused on understanding the genetic roots of spinal muscular atrophies within the Turkish population. This early research experience not only honed her skills in molecular diagnostics but also ignited her commitment to uncovering the genetic underpinnings of complex diseases. She further advanced her academic career by completing a PhD in Medical Genetics at the same university in 2004, where her dissertation revolved around pioneering techniques to detect mRNA in vertebrate tissue via in situ hybridization.

🧬 Professional Endeavors in Genetics

Since 2018, she has served as an Assistant Professor at the Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University. In this role, she has combined her deep expertise in medical genetics with teaching and mentorship responsibilities, fostering the next generation of scientists. Her academic presence in one of Turkey’s leading research institutes reflects both her commitment and her contributions to the broader scientific community. She also holds a European Certification in Project Management within EU Framework Programs (ECQA), which has enabled her to effectively lead and manage research projects aligned with global scientific standards.

🔬 Research Focus and Scientific Contributions

Her research encompasses a rich spectrum of topics, primarily centered around rare genetic disorders and the molecular intricacies of disease. She is particularly noted for her investigations into the molecular basis of rare genetic diseases and neuromuscular disorders, where she has explored genotype-phenotype correlations that enhance clinical diagnostics. Her work in gene expression regulation in pancreatic cancer has contributed to a deeper understanding of tumor biology, with implications for targeted therapies. She is also exploring third-generation sequencing technologies, particularly Oxford Nanopore Technologies (ONT), to facilitate real-time genomic insights. Her studies in genetic epidemiology and metabolic syndrome reflect a broader public health relevance, bridging the gap between molecular findings and population-level outcomes.

📚 Academic Impact and Publication Record

With 71 peer-reviewed publications to her name, her scholarly output is both prolific and impactful. She has accumulated 196 citations on Web of Science and 218 on Scopus, reflecting the influence of her work across multiple scientific domains. Her H-index of 7 (WoS) and 8 (Scopus) signifies consistent scholarly engagement and recognition in the academic community. These metrics underscore her role as a key contributor in advancing genetic science in Turkey and beyond.

🏅 Accolades and Recognition

While her work speaks volumes on its own, her achievements have been formally acknowledged through appointments and certifications that reinforce her leadership in the field. Her certification in EU project management is a testament to her administrative capabilities, enabling her to steer large-scale, interdisciplinary research initiatives. Her continued academic appointment at Istanbul University’s prestigious Aziz Sancar Institute places her among the foremost experts in experimental medical genetics in the region.

🌍 Influence in Scientific and Educational Circles

She is not only a researcher but also a skilled educator and communicator of science. Her bilingual proficiency in English and German, in addition to her native Turkish, has allowed her to build international collaborations and contribute to global scientific dialogues. Through teaching, supervision, and participation in multinational projects, she has influenced a broad audience—from medical students to advanced researchers—instilling in them a rigorous approach to genetic investigation and ethical science.

🔮 Legacy and Future Contributions

Looking ahead, her work in emerging sequencing technologies and personalized medicine positions her at the forefront of next-generation medical breakthroughs. As the landscape of genomics rapidly evolves, her role in shaping diagnostic tools and therapeutic strategies for rare and complex diseases will likely become even more prominent. Her trajectory suggests a legacy not only of scientific achievement but of mentorship, innovation, and a relentless pursuit of medical knowledge that bridges lab findings with real-world patient care.

Publication

  • Natural history of SMA IIIb: muscle strength decreases in a predictable sequence and magnitude – F Deymeer, P Serdaroglu, Y Parman, M Poda – 2008

 

  • Mapping of the second Friedreich’s ataxia (FRDAff2) locus to chromosome 9p23-p11: evidence for further locus heterogeneity – K Christodoulou, F Deymeer, P Serdaroğlu, C Özdemir, M Poda, … – 2001

 

  • Gender-modulated impact of apolipoprotein A5 gene (APOA5)−1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults – E Komurcu-Bayrak, A Onat, M Poda, SE Humphries, J Palmen, F Guclu, … – 2008

 

  • The S447X variant of lipoprotein lipase gene is associated with metabolic syndrome and lipid levels among Turks – E Komurcu-Bayrak, A Onat, M Poda, SE Humphries, J Acharya, … – 2007

 

  • Segmental distribution of muscle weakness in SMA III: implications for deterioration in muscle strength with time – F Deymeer, P Serdaroğlu, M Poda, Y Gülşen-Parman, T Özçelık, … – 1997

 

  • Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey – H Durmuş-Tekçe, Z Matur, MM Atmaca, M Poda, A Çakar, ÜH Ulaş, … – 2016

 

  • Pretreatment with octreotide modulates iNOS gene expression, mimics surgical delay, and improves flap survival – A Gözü, M Poda, EI Taskin, H Turgut, N Erginel-Ünaltuna, H Dogruman, … – 2010

 

  • CETP TaqIB polymorphism in Turkish adults: association with dyslipidemia and metabolic syndrome – B Özsait, EK Bayrak, M Poda, G Can, G Hergenç, A Onat, SE Humphries, … – 2008

 

  • Comparison of S gene mutations in patients with occult and chronic hepatitis B virus infection – B Cakal, B Cavus, A Atasoy, D Altunok, M Poda, M Bulakci, M Gulluoglu, … – 2022

 

  • The effects of IL28B rs12979860 and rs8099917 polymorphism on hepatitis B infection – B Cakal, B Cavus, A Atasoy, D Altunok, M Poda, M Bulakci, M Gulluoglu, … – 2022

 

🧾 Conclusion

In conclusion, her career reflects a harmonious blend of academic excellence, innovative research, and impactful teaching. Her work continues to illuminate the genetic mechanisms behind complex diseases while guiding future scientists through education and collaboration. With a growing influence in genomic research and translational medicine, she is well-positioned to leave a lasting legacy in the field of medical genetics, particularly through advancements in rare disease diagnostics and personalized healthcare strategies.

Zhenhua Wu | Neurogenetics | Distinguished Scientist Award

Published on by Neuroscientists

Dr. Zhenhua Wu | Neurogenetics | Distinguished Scientist Award

Dr. Zhenhua Wu, Exegenesis Bio, Inc ,United States.

Zhenhua Wu is a distinguished biotech entrepreneur and scientific leader with over 20 years of experience across the research and development value chain. As the founder, President, and CEO of Exegenesis Bio Inc., he has pioneered accessible, innovative gene therapies for patients with unmet medical needs. His journey spans rigorous academic beginnings, executive leadership in multiple biotechnology companies, and a steadfast commitment to global health advancement. Known for assembling world-class talent and making strategic decisions, Wu has played a key role in shaping the future of gene therapy through both scientific and business excellence.

Profile

Orcid

 

🎓 Early Academic Pursuits

Zhenhua Wu’s journey into the world of biotechnology and gene therapy was shaped by a solid academic foundation rooted in scientific rigor and innovation. During his early academic pursuits, he demonstrated a deep curiosity for biological systems and therapeutic sciences. This intellectual appetite laid the groundwork for his future endeavors in translational medicine, where scientific discovery meets real-world application. His academic training not only honed his research skills but also instilled a lifelong commitment to innovation in the life sciences.

💼 Professional Endeavors

With more than two decades of hands-on experience in the research and development value chain, Zhenhua Wu has established himself as a seasoned leader in biotechnology. He has served in executive roles across a range of biotech companies of various sizes and strategic focuses. In each capacity, he brought visionary leadership, guiding teams to deliver impactful solutions in the biomedical space. His career has been a progressive climb from scientific inquiry to corporate strategy, integrating a robust understanding of science with sharp business acumen.

🧬 Contributions and Research Focus

As a pioneer in the field of gene therapy, Zhenhua Wu’s contributions are both profound and multifaceted. He is the founder and current President and CEO of Exegenesis Bio Inc., a multinational gene therapy company based in Philadelphia, PA. Under his leadership, the company has developed a pipeline of innovative, affordable gene therapies designed to address high unmet medical needs. His research focus lies in advancing next-generation gene therapies that are not only effective but also accessible, aiming to bridge the gap between scientific breakthroughs and patient care.

🏆 Accolades and Recognition

Zhenhua Wu’s impactful career has earned him recognition as a visionary entrepreneur and scientific innovator. Though his biography remains modest in tone, his work has resonated across the biotech sector, attracting significant investment and strategic partnerships. His ability to build and lead a cutting-edge biotech company from the ground up has marked him as a key influencer in gene therapy, with accolades stemming from both industry peers and investors who recognize the value and promise of his work.

🌍 Impact and Influence

Through Exegenesis Bio, Zhenhua Wu has catalyzed a new wave of therapeutic innovation with global reach. His influence extends beyond the lab and boardroom, impacting regulatory conversations, patient advocacy movements, and international biotech development. By forging cross-continental collaborations and assembling a top-tier team of experts, he has ensured that the company is positioned as a global leader in gene therapy solutions, redefining what is possible in patient care and drug development.

🧭 Legacy and Future Contributions

Looking ahead, Zhenhua Wu continues to chart a path focused on expanding access to gene therapy on a global scale. His legacy is being built not only through the therapies under development but also through the culture of scientific integrity, innovation, and purpose that he has instilled in his company. He remains dedicated to mentoring future leaders, cultivating partnerships that push boundaries, and shaping a future where life-altering treatments are within reach for all who need them.

🧠 Visionary Leadership in Gene Therapy

At the heart of Zhenhua Wu’s professional identity is his role as a visionary leader in the fast-evolving field of gene therapy. His ability to connect scientific breakthroughs with patient-focused strategies has transformed Exegenesis Bio into a beacon of hope for countless individuals suffering from genetic diseases. Through his relentless pursuit of innovation, ethical leadership, and commitment to excellence, he continues to redefine what leadership means in the life sciences industry.

Publication

  • Title: Tunneling Nanotubes and Gap Junctions–Their Role in Long-Range Intercellular Communication during Development, Health, and Disease Conditions
    Authors: Ariazi J, Benowitz A, De Biasi V, den Boer M, Cherqui S, Cui H, Douillet N, Eugenin EA, Favre D, Goodman S, et al.
    Year: 2017

 

  • Title: Quantitative assessment of Aβ peptide in brain, cerebrospinal fluid and plasma following oral administration of γ-secretase inhibitor MRK-560 in rats
    Authors: Wu G, Wu Z, Na S, Hershey JC
    Year: 2015

 

  • Title: Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease
    Authors: Wu Z, Guo H, Chow N, Sallstrom J, Bell RD, Deane R, Brooks AI, Kanagala S, Rubio A, Sagare A, et al.
    Year: 2005

 

🔚 Conclusion

Zhenhua Wu’s career reflects the powerful intersection of science, leadership, and purpose. From building a visionary biotech enterprise to steering the development of transformative therapies, his contributions continue to resonate across the scientific community and healthcare industry. His legacy is not only defined by the innovations he leads today but also by the future he is helping shape—one where advanced gene therapies are more equitable, effective, and globally impactful. Through unwavering dedication and strategic foresight, he stands as a beacon of inspiration in the world of modern biotechnology.